Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2022 or the SUPER BUGS Act of 2022
This bill requires the Department of Health and Human Services (HHS) to seek to enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, which include drugs, biological products, and medical devices. HHS shall report to Congress a strategy for achieving this goal.
[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9303 Introduced in House (IH)]
<DOC>
117th CONGRESS
2d Session
H. R. 9303
To direct the Secretary of Health and Human Services, in consultation
with the Secretary of State, to formulate a strategy for the Federal
Government to secure support from foreign countries, multilateral
organizations, and other appropriate entities to facilitate the
development and commercialization of qualified pandemic or epidemic
products, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
November 15, 2022
Mr. Levin of California (for himself and Mr. Ferguson) introduced the
following bill; which was referred to the Committee on Foreign Affairs
_______________________________________________________________________
A BILL
To direct the Secretary of Health and Human Services, in consultation
with the Secretary of State, to formulate a strategy for the Federal
Government to secure support from foreign countries, multilateral
organizations, and other appropriate entities to facilitate the
development and commercialization of qualified pandemic or epidemic
products, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Saving Us from Pandemic Era
Resistance by Building a Unified Global Strategy Act of 2022'' or the
``SUPER BUGS Act of 2022''.
SEC. 2. INTERNATIONAL STRATEGY FOR DEVELOPMENT OF QUALIFIED PANDEMIC OR
EPIDEMIC PRODUCTS.
(a) Strategy.--
(1) In general.--Not later than 18 months after the date of
enactment of this Act, the Secretary of Health and Human
Services, in consultation with the Secretary of State, shall--
(A) formulate a strategy for the Federal Government
to secure support from foreign countries, multilateral
organizations, and other appropriate entities to
facilitate the development and commercialization of
qualified pandemic or epidemic products, including such
products to address antimicrobial resistant pathogens--
(i) with pandemic potential; or
(ii) that are priority pathogens; and
(B) submit such strategy to the appropriate
committees of Congress.
(2) Contents.--The strategy under paragraph (1) shall--
(A) provide for the process the Federal Government
would use to enter into arrangements with foreign
countries, multilateral organizations, and other
appropriate entities in certain circumstances;
(B) strive to secure equitable contributions among
participating countries, organizations, and entities;
(C) focus on global priorities but allow
participating countries, organizations, and entities to
emphasize national or regional issues of importance;
(D) seek to ensure such arrangements are harmonized
with each other and with other relevant arrangements to
prevent duplication of effort and to efficiently
distribute funds;
(E) provide for collaboration so as to allocate
joint or individual responsibility across participating
countries, organizations, and entities for the
development and commercialization of particular
qualified pandemic or epidemic products, where such
collaboration is spelled out beforehand in such
arrangements;
(F) provide for the stewardship of qualified
pandemic or epidemic products developed pursuant to the
strategy;
(G) define criteria so that scarce funds are
allocated to advance qualified pandemic or epidemic
products that can achieve the greatest positive impact
on human health, including unprecedented approaches to
preventing, treating, and diagnosing infectious
diseases;
(H) consider approaches including securing
contracts with the private sector, entering into
public-private partnerships, implementing alternative
payment models, and streamlining regulatory approval
processes; and
(I) be synchronized with United States pandemic
preparedness priorities, such as the U.S. National
Action Plan for Combating Antibiotic-Resistant Bacteria
(CARB).
(b) Arrangements With Foreign Countries and Multilateral
Organizations.--The Secretary of Health and Human Services, in
consultation with the Secretary of State, shall seek to enter into
arrangements with foreign countries, multilateral organizations, and
other appropriate entities to implement the strategy under subsection
(a).
(c) Definition.--In this section:
(1) The term ``priority pathogens'' means pathogens
identified in the latest Centers for Disease Control and
Prevention Antimicrobial Threats Report, the World Health
Organization Global Priority Pathogens List, or a successor
report or list.
(2) The term ``qualified pandemic or epidemic product'' has
the meaning given to such term in section 319F-3 of the Public
Health Service Act (42 U.S.C. 247d-6b).
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Foreign Affairs.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line